METHYLNALTREXONE BROMIDE | N021964 | SALIX PHARMACEUTICALS INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
BAUSCH HEALTH COMPANIES INC et al v. GLAND PHARMA LIMITED 8 patentsANDA 216836, 216965methylnaltrexone bromide | D.N.J. | 2022-02-22 | Terminated 2022-07-25 | — |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARAMACEUTICALS, INC. et al 7 patentsANDA 208592, 208594methylnaltrexone bromide | D.N.J. | 2017-09-01 | Terminated 2018-06-04 | — |
Valeant Pharmaceuticals International, Inc. et al 6 patentsANDA 209682methylnaltrexone bromide | S.D.N.Y. | 2017-08-28 | Terminated 2017-11-30 | — |
VALEANT PHARMACEUTICALS INTERNATIONAL INC. et al v. PAR STERILE PRODUCTS, LLC et al 6 patentsANDA 209682methylnaltrexone bromide | D.N.J. | 2017-08-25 | Terminated 2018-05-15 | — |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. ACTAVIS LLC et al 5 patentsANDA 208112methylnaltrexone bromide | D.N.J. | 2015-11-30 | Terminated 2016-07-22 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).